Scientists report they have successfully treated hemophilia B by giving sufferers gene therapy. When they infuse a gene for the correct blood-clotting factor, it's taken up by the patient who then can produce it on their own. So they no longer have to inject clotting factor to avoid potentially crippling or fatal consequences.
